Spinal astrocytes have been implicated in the pathogenesis of late-onset SMA, where early reductions in glutamate transport proteins, primarily excitatory amino acid transporter 1 (EAAT1), lead to glutamate excitotoxicity and subsequent MN loss (Table 1). Here, SLC1A3 is linked to proximal spinal muscular atrophy.